ARCHIVES

Drugs and Targets: EU approves Imbruvica in MCL, CLL

This article is from The Cancer Letter archive.

Vol. 40 No. 40 | October 24, 2014

Download PDF Visit The Full Archive

Related Articles

SEC Investigating Bristol-Myers’ Sales Statements

July 12, 2002

Cancer Centers Branch To Be ‘More Proactive,’ Kimes Tells NCAB

January 5, 1990

“Roller-Coaster Budget” For NIH Criticized On Capitol Hill; $1 Billion Cut By FY 2000?

March 17, 1995

NIH Plans Consensus Conference On Ovarian Cancer April 5-7

January 28, 1994

Going private may allow US Oncology to restructure, respond to Medicare cuts; equity investment firm offers to purchase shares.

April 23, 2004

FDA Advisors Discuses Establishment of Standards for Showing Equivalence

December 17, 1999